• Source: Camizestrant

Camizestrant is an investigational new drug that is being evaluated to treat breast cancer. It is an estrogen receptor alpha antagonist and a selective estrogen receptor degrader (SERD).




References

Kata Kunci Pencarian:

• Camizestrant
• Spironolactone
• Norethisterone
• Nicotinamide
• Estrogen
• Niacin
• DDT
• Steroid
• Testosterone
• Dihydrotestosterone